journal
https://read.qxmd.com/read/38602486/current-state-of-endothelial-cell-therapy
#1
JOURNAL ARTICLE
Ellen H Koo
PURPOSE OF REVIEW: Currently, there is heightened interest surrounding endothelial cell therapy for the treatment of corneal edema. The purpose of this review article is to describe and summarize the background information as well as the research surrounding the emerging treatment modalities for endothelial cell therapy. RECENT FINDINGS: Marked advancements have been made in the translational research in this area, and increasing refinements have been demonstrated in the treatment protocols for cell therapy...
April 12, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38484226/understanding-network-meta-analysis-methodology-for-the-ophthalmologist
#2
JOURNAL ARTICLE
Mark Phillips, Varun Chaudhary
PURPOSE OF REVIEW: Over the past decade, the number of studies published using network meta-analyses (NMAs) has rapidly increased, and there have been continued advancements to further advance this analysis approach. Due to the fast moving and changing landscape in the infancy of NMA methodology, there is a lack of consistency and standardization for this approach. This article aims to summarize the crucial components of an NMA for both future readers, and for potential NMA authors. RECENT FINDINGS: Key components of NMAs include, but are not limited to, reporting the proposed analysis methods, assessment of risk of bias within the included studies, reporting the overall quality of the available evidence, and defining the parameters in which the results will be presented...
March 15, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38484223/new-forays-into-measurement-of-ocular-biomechanics
#3
JOURNAL ARTICLE
Emma Hammelef, Christopher J Rapuano, Dominick A Benedetto, Zeba A Syed, Jonathan S Myers, M Reza Razeghinejad, Fred H Silver, Jose S Pulido
PURPOSE OF REVIEW: The field of corneal biomechanics has rapidly progressed in recent years, reflecting technological advances and an increased understanding of the clinical significance of measuring these properties. This review will evaluate in-vivo biomechanical properties obtained by current technologies and compare them regarding their relevance to established biomechanical properties obtained by gold-standard ex-vivo techniques normally conducted on elastic materials. RECENT FINDINGS: Several new technologies have appeared in recent years, including vibrational optical coherence tomography (VOCT) and the corneal indentation device (CID)...
March 14, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38465910/systemic-medications-for-sickle-cell-disease-and-potential-applications-for-sickle-cell-retinopathy
#4
JOURNAL ARTICLE
Anupam K Garg, Adrienne W Scott
PURPOSE OF REVIEW: To review the literature evaluating systemic medications for treatment of sickle cell disease (SCD) and their applications for sickle cell retinopathy. RECENT FINDINGS: Prior studies have demonstrated the efficacy of traditional systemic therapies in reducing the risk of development of sickle cell retinopathy. Since 2017, several new and promising disease-modifying therapies for sickle cell disease have been approved for clinical use, including the first genetic therapies such as exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel)...
March 11, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38441066/gene-therapy-for-age-related-macular-degeneration-potential-feasibility-and-pitfalls
#5
JOURNAL ARTICLE
Sean T Berkowitz, Avni P Finn
PURPOSE OF REVIEW: The landscape for age-related macular degeneration (AMD) is rapidly changing with addition of biosimilars and now United States Food and Drug Administration (FDA) approved nonneovascular AMD (nnAMD) treatment options. These developments have inspired a burgeoning pipeline of gene therapy approaches focused on similar antivascular endothelial growth factors (VEGF) and complement related pathways. Historic and more recent setbacks in the gene therapy pipeline, including intraocular inflammatory reactions, have raised important concerns for adverse events related to AMD therapeutics both for gene and nongene approaches...
March 5, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38421937/geographic-atrophy-current-and-future-therapeutic-agents-and-practical-considerations-for-retinal-specialists
#6
JOURNAL ARTICLE
Priya Vakharia, David Eichenbaum
PURPOSE OF REVIEW: Geographic atrophy (GA) from age-related macular degeneration (AMD) remains a leading cause of vision loss. The purpose of this review is to summarize currently available intravitreal therapeutics, and discuss pipeline therapeutics that are currently in clinical trials. RECENT FINDINGS: The FDA approval of pegcetacoplan and avacincaptad pegol, both approved in 2023, represent the first therapeutics to treat GA. These are delivered via intravitreal injections, and have been shown to slow progression of GA...
February 29, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38334288/chatgpt-enters-the-room-what-it-means-for-patient-counseling-physician-education-academics-and-disease-management
#7
JOURNAL ARTICLE
Bita Momenaei, Hana A Mansour, Ajay E Kuriyan, David Xu, Jayanth Sridhar, Daniel S W Ting, Yoshihiro Yonekawa
PURPOSE OF REVIEW: This review seeks to provide a summary of the most recent research findings regarding the utilization of ChatGPT, an artificial intelligence (AI)-powered chatbot, in the field of ophthalmology in addition to exploring the limitations and ethical considerations associated with its application. RECENT FINDINGS: ChatGPT has gained widespread recognition and demonstrated potential in enhancing patient and physician education, boosting research productivity, and streamlining administrative tasks...
February 8, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38345051/enhanced-durability-and-evolution-of-retreatment-criteria-of-intravitreal-antivascular-endothelial-growth-factor-agents-for-diabetic-macular-edema
#8
JOURNAL ARTICLE
Nikhil K Mandava, Ajay E Kuriyan, Allen C Ho, Jason Hsu, Carl D Regillo, Michael A Klufas
PURPOSE OF REVIEW: The increasing prevalence of diabetic macular edema (DME) necessitates an updated review of treatment modalities. While the shift from laser to anti-vascular endothelial growth factor (anti-VEGF) therapy has transformed patient outcomes, benefits of these agents are not fully realized in real-world implementation relative to the setting of controlled clinical trials. This review outlines the evolution of intravitreal anti-VEGF treatment extension protocols for DME that reflect efforts to address treatment adherence challenges while optimizing visual outcomes...
February 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38295156/weight-loss-bariatric-surgery-and-novel-antidiabetic-drugs-effects-on-diabetic-retinopathy-a-review
#9
JOURNAL ARTICLE
Alejandro M Perez, Emily Neag, Jayanth Sridhar, Basil K Williams
PURPOSE OF REVIEW: Diabetic retinopathy (DR) is a leading cause of visual impairment, and the increasing prevalence of diabetes and obesity will impact rates of visual impairment moving forward. Our review aims to synthesize the current body of evidence regarding the impact of lifestyle interventions, such as weight loss, bariatric surgery, and novel antidiabetic drugs, on DR. RECENT FINDINGS: Literature review revealed insufficient evidence regarding the impact of weight loss on DR...
January 31, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38276971/cell-therapy-for-retinal-disease
#10
JOURNAL ARTICLE
Goutham R Yalla, Ajay E Kuriyan
PURPOSE OF REVIEW: This review presents an update on completed stem cell therapy trials aimed at retinal diseases. RECENT FINDINGS: In recent years, several clinical trials have been conducted examining the safety and role of cell therapy in diseases, including age-related macular degeneration, Stargardt's macular dystrophy, and retinitis pigmentosa. Studies have utilized a variety of cell lines, modes of delivery, and immunosuppressive regimens. The prevalence of fraudulent cell therapy clinics poses threats to patients...
January 25, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38518069/cranial-nerve-involvement-visual-complications-and-headache-syndromes-in-lyme-disease
#11
REVIEW
Caleb R S McEntire, Bart K Chwalisz
PURPOSE OF REVIEW: To provide a summary of the visual manifestations and cranial neuropathies seen in Lyme disease. RECENT FINDINGS: Lyme facial palsy remains the most common manifestation of Lyme neuroborreliosis. Recent investigations show likely evidence of vagal involvement in Lyme disease. SUMMARY: The literature on Lyme neuroborreliosis continues to evolve. Lyme disease can affect nearly any cranial nerve in addition to causing various headache syndromes...
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38518068/editorial
#12
JOURNAL ARTICLE
Sunir J Garg, Jason Hsu
No abstract text is available yet for this article.
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38518067/the-ever-evolving-landscape-of-medical-and-surgical-management-of-retinal-disease
#13
JOURNAL ARTICLE
Ajay E Kuriyan, Jayanth Sridhar
No abstract text is available yet for this article.
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38421954/retinal-arterial-and-vein-occlusion-is-surgery-ever-indicated
#14
REVIEW
Kazuaki Kadonosono, Maiko Inoue, Yasuo Yanagi
PURPOSE OF REVIEW: To highlight the recent progression in surgical treatments for central retinal vein occlusion (CRVO) and central retinal artery occlusion (CRAO). RECENT FINDINGS: Anti-VEGF treatment, accepted as a primary treatment for CRVO, is unable to effectively treat all types of the diseases. Regarding CRAO, there are not any accepted therapies available. There have however been recent innovations in surgery, such as utilizing robotics-assisted tools in cannulation procedures for central retinal artery occlusion, or micro-cystotomy for refractory macular edema resulting from ischemic CRVO...
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38364771/review-and-analysis-of-history-and-utilization-of-pneumatic-retinopexy-after-pneumatic-retinopexy-versus-vitrectomy-for-the-management-of-primary-rhegmatogenous-retinal-detachment-outcomes-randomized-trial-pivot
#15
JOURNAL ARTICLE
Serena Shah, Brandon Chou, Marissa Patel, Arjun Watane, Lea Shah, Nicolas Yannuzzi, Jayanth Sridhar
PURPOSE OF REVIEW: We describe the history and series results of pneumatic retinopexy (PnR)and provide an analysis of PnR utilization after publication of results of pneumatic retinopexy versus vitrectomy for the management of primary rhegmatogenous retinal detachment outcomes randomized trial (PIVOT). RECENT FINDINGS: No significant trends were found for average number of services ( P  = 0.153) of PnR after the publication of PIVOT results. SUMMARY: PnR is a rhegmatogenous retinal detachment (RRD) repair technique that was first described in the early 1900 s and has evolved over time to become a modern-day, minimally invasive, underutilized treatment option...
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38323405/editorial-introduction
#16
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
March 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38295153/recent-developments-of-telemedicine-in-glaucoma
#17
REVIEW
Jason J Jo, Louis R Pasquale
PURPOSE OF REVIEW: Telemedicine has an increasingly significant role in the fields of ophthalmology and glaucoma. This review covers recent advancements in the development and optimization of teleglaucoma techniques and applications. RECENT FINDINGS: Glaucoma monitoring and diagnosis via remote tonometry, perimetry, and fundus imaging have become a possibility based on recent developments. Many applications work in combination with smart devices, virtual reality, and artificial intelligence and have been tested in patient populations against conventional "reference-standard" measurement tools, demonstrating promising results...
March 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38117663/genes-as-drugs-for-glaucoma-latest-advances
#18
REVIEW
Teresa BorrĂ¡s, Michelle Stepankoff, John Danias
PURPOSE OF REVIEW: To provide the latest advances on the future use of gene therapy for the treatment of glaucoma. RECENT FINDINGS: In preclinical studies, a number of genes have been shown to be able to reduce elevated intraocular pressure (IOP), and to exert neuroprotection of the retinal ganglion cells. These genes target various mechanisms of action and include among others: MMP3 , PLAT, IκB, GLIS, SIRT, Tie-2, AQP1. Some of these as well as some previously identified genes ( MMP3, PLAT, BDNF, C3, TGFβ, MYOC, ANGPTL7 ) are starting to move onto drug development...
March 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38108372/glaucoma-surgical-procedures-under-development
#19
REVIEW
Ariana M Levin, Arsham Sheybani
PURPOSE OF REVIEW: Rapid innovation in glaucoma surgery is expanding surgical options in the angle, subconjunctival space, and supraciliary space. RECENT FINDINGS: Advancements in glaucoma surgery make it possible for surgeons to provide treatments with less risk. In particular, new devices and lasers are available for minimally invasive glaucoma surgeries. There are also new implants and techniques for bleb-forming glaucoma surgery. SUMMARY: As glaucoma surgeons have access to an increasing number of procedures, devices, and treatments, it is important for evidence to drive decision-making...
March 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38018802/cataract-surgery-in-setting-of-ocular-surface-disease
#20
REVIEW
Enrica Sarnicola, Caterina Sarnicola, Maddalena De Bernardo, Nicola Rosa, Vincenzo Sarnicola
PURPOSE OF REVIEW: The purpose of this article is to review the available strategies to successfully identify and manage ocular surface disease (OSD) pre, intra and post-cataract surgery. RECENT FINDINGS: Cataract surgery and OSD have an intricate relationship: the surgical procedure can induce or exaggerate OSD symptoms, while OSD can negatively impact surgical refractive outcomes and increase the rate of postoperative complications. SUMMARY: Improving the health and stability ocular surface is the key to enhance post cataract surgery refractive outcomes and avoid complications...
March 1, 2024: Current Opinion in Ophthalmology
journal
journal
30503
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.